Our investigation provides novel insights into Gpr35’s neuroprotective function in PD, revealing that genetic ablation of Gpr35 aggravates disease pathology through enhanced motor deficits, accelerated dopaminergic neuron degeneration, and amplified neuroinflammatory responses in PD mouse models. Here, GPR35 is linked to Parkinson disease.